Real-time SEC alerts Start Free →
Profitelligence
Tempus AI Inc.
TEM MEDIUM Impact

Tempus AI Inc.

Tempus AI, Inc. Amends Credit Agreement to Fund Acquisition of Ambry Genetics Corporation

| 8-K |Healthcare

Summary

On February 3, 2025, Tempus AI, Inc. amended its Credit Agreement to include an additional $200 million in senior secured term loan commitments and $100 million in priority revolving commitments. The amendment was made to provide funding, in part, for the acquisition of Ambry Genetics Corporation. The Term Loans mature in September 2027, while the Third Amendment Term Loan Facility and the Priority ABL Facility mature on February 3, 2030. The Credit Agreement contains customary representations, warranties, and covenants, including restrictions on incurring additional indebtedness and paying dividends.

Profitelligence Profitelligence Alerts

Get alerts for TEM

Be first to know when Tempus AI Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Financial Instrument Agreement New Debt Issued No viable tag

Exhibits (1)

Advertisement

About Tempus AI Inc.

Tempus AI Inc. is a pioneering technology company specializing in the development and application of artificial intelligence solutions across various industries. Its primary function is to harness AI-driven insights to enhance operational efficiency and decision-making processes for enterprises. Tempus AI Inc. is at the forefront of integrating machine learning into sectors such as healthcare, finance, and logistics, where predictive data analytics can provide substantial competitive advantages. The company delivers bespoke AI platforms that enable organizations to streamline complex data sets into actionable intelligence. Its expertise extends to natural language processing and computer vision, offering comprehensive AI tools that drive innovation and efficiency. As a significant player in the tech market, Tempus AI Inc. contributes to setting industry standards for AI deployment, impacting how businesses leverage intelligent technology to improve outcomes and strategic planning. Founded with a mission to propel the development of intelligent systems, Tempus AI Inc. remains a vital contributor to the digital transformation of multiple industries, facilitating the transition towards a more data-driven future.

Exchange: NASDAQ Industry: Health Information Services Company Website →

Official SEC Documents

TEM
TEM Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement